Anmada Nayak

1.2k total citations
25 papers, 889 citations indexed

About

Anmada Nayak is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Anmada Nayak has authored 25 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Toxicology. Recurrent topics in Anmada Nayak's work include Cancer therapeutics and mechanisms (7 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and RNA Interference and Gene Delivery (5 papers). Anmada Nayak is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and RNA Interference and Gene Delivery (5 papers). Anmada Nayak collaborates with scholars based in India, United States and New Zealand. Anmada Nayak's co-authors include Chanakya Nath Kundu, Sumit Siddharth, Sarita Das, Deepika Nayak, Shakti Ranjan Satapathy, Dipon Das, Prasad V. Bharatam, Sankar K. Guchhait, Chinmayee Sethy and Uttam Chand Banerjee and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Anmada Nayak

25 papers receiving 880 citations

Peers

Countries citing papers authored by Anmada Nayak

Since Specialization

Citations

This map shows the geographic impact of Anmada Nayak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anmada Nayak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anmada Nayak more than expected).

Fields of papers citing papers by Anmada Nayak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anmada Nayak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anmada Nayak. The network helps show where Anmada Nayak may publish in the future.

Co-authorship network of co-authors of Anmada Nayak

This figure shows the co-authorship network connecting the top 25 collaborators of Anmada Nayak. A scholar is included among the top collaborators of Anmada Nayak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anmada Nayak. Anmada Nayak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Druggable UHRF1/DNMT1/GLI Complex Regulates Sonic Hedgehog–Dependent Tumor Growth 2022 ·Molecular Cancer Research ·Fan Yang, Jezabel Rodríguez‐Blanco, Jun Long, Marzena Swiderska‐Syn, (unknown), (unknown), Chen Shen, Anmada Nayak, Yuguang Ban, (unknown), (unknown), Heather J. McCrea, Anthony J. Capobianco, Nagi G. Ayad, David J. Robbins	6
2	The Casein kinase 1α agonist pyrvinium attenuates Wnt-mediated CK1α degradation via interaction with the E3 ubiquitin ligase component Cereblon 2022 ·Journal of Biological Chemistry ·Chen Shen, Anmada Nayak, Leif R. Neitzel, Fan Yang, Bin Li, Charles H. Williams, Charles C. Hong, Yashi Ahmed, Ethan Lee, David J. Robbins	5
3	Developmental regulation of Wnt signaling by Nagk and the UDP-GlcNAc salvage pathway 2019 ·Mechanisms of Development ·Leif R. Neitzel, (unknown), Anmada Nayak, (unknown), Hassina Benchabane, (unknown), (unknown), (unknown), (unknown), (unknown), James G. Patton, David J. Robbins, Yashi Ahmed, Ethan Lee	16
4	Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation 2019 ·Cellular Oncology ·Anmada Nayak, Sarita Das, Deepika Nayak, Chinmayee Sethy, Satya Narayan, Chanakya Nath Kundu	39
5	Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway 2019 ·The International Journal of Biochemistry & Cell Biology ·Deepika Nayak, Neha Tripathi, Deepika Kathuria, Sumit Siddharth, Anmada Nayak, Prasad V. Bharatam, Chanakya Nath Kundu	36
6	The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-β4 2018 ·The International Journal of Biochemistry & Cell Biology ·Sumit Siddharth, Anmada Nayak, Sarita Das, Deepika Nayak, (unknown), Michael D. Wyatt, Chanakya Nath Kundu	44
7	Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner 2018 ·Nanomedicine Nanotechnology Biology and Medicine ·Shakti Ranjan Satapathy, Anmada Nayak, Sumit Siddharth, Sarita Das, Deepika Nayak, Chanakya Nath Kundu	52
8	Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis 2017 ·The International Journal of Biochemistry & Cell Biology ·Sumit Siddharth, (unknown), Sarita Das, Anmada Nayak, Deepika Nayak, Chinmayee Sethy, Michael D. Wyatt, Chanakya Nath Kundu	77
9	Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage 2017 ·Scientific Reports ·Sumit Siddharth, Anmada Nayak, Deepika Nayak, Birendra Kumar Bindhani, Chanakya Nath Kundu	44
10	Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis 2017 ·APOPTOSIS ·Sarita Das, Neha Tripathi, Sumit Siddharth, Anmada Nayak, Deepika Nayak, Chinmayee Sethy, Prasad V. Bharatam, Chanakya Nath Kundu	27
11	Nanoquinacrine caused apoptosis in oral cancer stem cells by disrupting the interaction between GLI1 and β catenin through activation of GSK3β 2017 ·Toxicology and Applied Pharmacology ·Anmada Nayak, Sumit Siddharth, Sarita Das, Deepika Nayak, Chinmayee Sethy, Chanakya Nath Kundu	21
12	Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1 2016 ·Scientific Reports ·Anmada Nayak, Shakti Ranjan Satapathy, Dipon Das, Sumit Siddharth, Neha Tripathi, Prasad V. Bharatam, Chanakya Nath Kundu	50
13	Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα 2016 ·European Journal of Medicinal Chemistry ·Garima Priyadarshani, (unknown), Anmada Nayak, Uttam Chand Banerjee, Chanakya Nath Kundu, Sankar K. Guchhait	45
14	SURVIVIN as a marker for quiescent-breast cancer stem cells—An intermediate, adherent, pre-requisite phase of breast cancer metastasis 2016 ·Clinical & Experimental Metastasis ·Sumit Siddharth, Sarita Das, Anmada Nayak, Chanakya Nath Kundu	39
15	ABT-888 and quinacrine induced apoptosis in metastatic breast cancer stem cells by inhibiting base excision repair via adenomatous polyposis coli 2016 ·DNA repair ·Sumit Siddharth, Deepika Nayak, Anmada Nayak, Sarita Das, Chanakya Nath Kundu	27
16	Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade 2016 ·Biochemical Pharmacology ·Ranjan Preet, Sumit Siddharth, Shakti Ranjan Satapathy, Sarita Das, Anmada Nayak, Dipon Das, Michael D. Wyatt, Chanakya Nath Kundu	21
17	Resveratrol and curcumin synergistically induces apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21Waf1/Cip1 mediated inhibition of Hh-Gli signaling 2015 ·The International Journal of Biochemistry & Cell Biology ·Purusottam Mohapatra, Shakti Ranjan Satapathy, Sumit Siddharth, Dipon Das, Anmada Nayak, Chanakya Nath Kundu	38
18	NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K–AKT cascade 2015 ·Cancer Chemotherapy and Pharmacology ·Dipon Das, Shakti Ranjan Satapathy, Sumit Siddharth, Anmada Nayak, Chanakya Nath Kundu	42
19	Anti-malarials are anti-cancers and vice versa – One arrow two sparrows 2015 ·Acta Tropica ·Chanakya Nath Kundu, Sarita Das, Anmada Nayak, Shakti Ranjan Satapathy, Dipon Das, Sumit Siddharth	23
20	Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic Inhibitors 2015 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Neha Trivedi, Vikas Chaudhary, Anmada Nayak, Sankar K. Guchhait, Uttam Chand Banerjee, Prasad V. Bharatam, Chanakya Nath Kundu	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact